Capricor Therapeutics's market cap is currently $725.24M. The company's EPS TTM is $-1.062; its P/E ratio is ―; Capricor Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 25.18M	$ 2.55M	$ 244.90K	$ 310.25K	$ 1.01M
Gross Profit	$ 24.11M	$ 1.85M	$ -799.00	$ -8.15M	$ -4.14M
Operating Income	$ -24.08M	$ -29.70M	$ -20.94M	$ -13.69M	$ -7.73M
EBITDA	$ -23.01M	$ -29.16M	$ -20.69M	$ -13.55M	$ -7.56M
Net Income	$ -22.29M	-	$ -19.41M	$ -13.48M	$ -7.38M
Balance Sheet
Cash & Short-Term Investments	$ 39.49M	$ 41.42M	$ 34.89M	$ 32.67M	$ 9.89M
Total Assets	$ 58.73M	$ 50.09M	$ 41.33M	$ 34.62M	$ 11.11M
Total Debt	$ 2.24M	$ 2.56M	$ 2.87M	$ 318.16K	$ 3.38M
Net Debt	$ -12.46M	$ -7.04M	$ -32.01M	$ -32.35M	$ -523.07K
Total Liabilities	$ 36.13M	$ 38.31M	$ 9.96M	$ 6.42M	$ 4.27M
Stockholders' Equity	$ 22.60M	$ 11.79M	$ 31.37M	$ 28.20M	$ 6.84M
Cash Flow
Free Cash Flow	$ -27.64M	$ 1.56M	$ -18.01M	$ -10.60M	$ -6.82M
Operating Cash Flow	$ -25.60M	$ 4.92M	$ -16.81M	$ -10.05M	$ -6.82M
Investing Cash Flow	$ 5.11M	$ -35.07M	$ -1.20M	$ 5.44M	$ -3.00M
Financing Cash Flow	$ 25.58M	$ 4.87M	$ 20.23M	$ 33.38M	$ 9.18M

Currency in USD

Capricor Therapeutics Earnings and Revenue History

Income Statement >

Capricor Therapeutics Debt to Assets

Balance Sheet >

Capricor Therapeutics Cash Flow

Cash Flow >

Capricor Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing